RayzeBio (RYZB) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Skip Charts & View Estimated and Actual Earnings Data

RYZB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RYZB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RayzeBio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.08)($1.08)($1.08)
Q2 20241($0.06)($0.06)($0.06)
Q3 20241($0.09)($0.09)($0.09)
Q4 20241($0.17)($0.17)($0.17)
FY 20244($1.40)($1.40)($1.40)

RayzeBio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023Q3 2023($0.67)($1.26)($0.59)($1.26)--

RayzeBio Earnings - Frequently Asked Questions

How much profit does RayzeBio generate each year?

RayzeBio (NASDAQ:RYZB) has a recorded net income of -$68.60 million. RYZB has generated $0.00 earnings per share over the last four quarters.

What is RayzeBio's EPS forecast for next year?

RayzeBio's earnings are expected to grow from ($2.82) per share to ($1.57) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RYZB) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners